Subscribe to this Blog


Blog Archive

Subscribe Via Email

Enter your email address:

Wednesday, June 06, 2007

Import Ban Trends for Safety and Security?

Recently the US government put in place import bans on Chinese toothpaste following the release that several distributors and manufacturers based of the China have been utilizing dangerous products in the goods that they distribute around the world. The information came to light after several children died in Panama.

This ban was put in place in relation to bathroom products and the ingredients are going to cough syrup. Does this import ban or blockade indicate greater changes in future import rejections for many other products. There has been a great deal of talk about changing the restrictions on the import of dietary supplements. Might the FDA reconsider their position on these items given the current circumstances?

And is that a step forward or a step backwards. There are many people on the other side of the equation that would like to see more free trade of prescription drugs even from countries that have access to cheaper prescription drugs than what we have in the United States. The FDA would counter that some of those drugs are not up to the quality of US standards and the toothpaste example may prove the point.

There's a fine line to walk between big brother protecting us, and big brother been manipulated into gouging consumers and business. Each year more more products come out to help us in various different fashions and many of them are so continuing to fall under the category of supplements. For example you can take dietary supplements to basically provide topical vitamins to your skin care product known as skinceuticals.

Innovation, marketing plans, and consumers demand is driving a constantly evolving marketplace, and the FDA can barely keep up on a good day. It could even be possible that they are over reacting and minor issues and under reacting in major ones. That type of from the hip reaction does not make for conducive business environments.

0 comments: